PARP inhibitors – a cancer drug discovery story | Professor Ruth Plummer FMedSci

Newcastle Discover: The Journey of a Cancer Treatment with Professor Ruth PlummerПодробнее

ESMO 2010: PARP inhibitorsПодробнее

DNA repair inhibitors to overcome drug resistanceПодробнее

PARP inhibitors for ovarian cancerПодробнее

How PARP inhibitors (PARPi) workПодробнее

PARP-inhibitors: A New Generation of Cancer DrugsПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Dr. Ledermann on Response to Rucaparib in Recurrent Ovarian CancerПодробнее

An Overview of PARP Inhibitors in Ovarian CancerПодробнее

Ask an Expert: How Do PARP Inhibitors Work?Подробнее

A surgeon's view on curing cancer | Professor John PrimroseПодробнее

PARP Inhibitors and Indications in Ovarian CancerПодробнее

Molecular Oncology: Past, Present and Future of Anti-Cancer Drug DesignПодробнее

PARP Inhibitors: Deciding Among the Available AgentsПодробнее

Development and clinical indications of PARP inhibitorsПодробнее

PARP Inhibitors in Recurrent Ovarian CancerПодробнее

A Taste of the Research World - Prof Ruth PlummerПодробнее

CRUK | Featured stories | Professor Iain McNeishПодробнее